164 related articles for article (PubMed ID: 3304609)
21. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance.
Allred DC; Bustamante MA; Daniel CO; Gaskill HV; Cruz AB
Arch Surg; 1990 Jan; 125(1):107-13. PubMed ID: 1688490
[TBL] [Abstract][Full Text] [Related]
22. Immunoperoxidase localization of estrogen receptors in human brest carcinoma.
Garancis JC; Miller LS; Tomita JT; Tieu TM; Clowry LJ
Cancer Detect Prev; 1983; 6(1-2):235-9. PubMed ID: 6192919
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine-needle aspirates of breast cancer.
Reiner A; Reiner G; Spona J; Teleky B; Kolb R; Holzner JH
Am J Clin Pathol; 1987 Oct; 88(4):399-404. PubMed ID: 3661495
[TBL] [Abstract][Full Text] [Related]
24. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas.
Skoog L; Humla S; Isaksson S; Tani E
Diagn Cytopathol; 1990; 6(2):95-8. PubMed ID: 2186900
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of oestrogen receptor in symptomatic breast carcinoma, using fine needle aspiration cytology.
Cuthbert A; Herbert A; Coddington R; Theaker J; Taylor I; Royle GT
Cytopathology; 1990; 1(6):339-47. PubMed ID: 2101680
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of estrogen receptors in cells obtained by fine needle aspiration from human mammary carcinomas.
Azavedo E; Baral E; Skoog L
Anticancer Res; 1986; 6(2):263-6. PubMed ID: 3518595
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical detection of estrogen receptors and image analysis (SAMBA 200) in breast carcinomas].
Charpin C; Martin PM; Andrac L; Lavaut MN; Vacheret H; Habib MC; Toga M
Ann Pathol; 1988; 8(3):196-210. PubMed ID: 3178938
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor determination in fine needle aspirates of the breast. Correlation with histologic grade and comparison with biochemical analysis.
Lozowski MS; Mishriki Y; Chao S; Grimson R; Pai P; Harris MA; Lundy J
Acta Cytol; 1987; 31(5):557-62. PubMed ID: 3314302
[TBL] [Abstract][Full Text] [Related]
29. Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors.
Masood S; Lu L; Rodenroth N
Mod Pathol; 1990 Nov; 3(6):724-8. PubMed ID: 1702213
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical estrogen receptor assay: quantitation by image analysis.
el-Badawy N; Cohen C; DeRose PB; Sgoutas D
Mod Pathol; 1991 May; 4(3):305-9. PubMed ID: 2068055
[TBL] [Abstract][Full Text] [Related]
31. Imprint immunocytochemistry of estrogen receptors in breast carcinoma.
Moriya T; Manabe T; Tsukayama C; Yamashita K; Ipponsugi S; Sonoo H; Senoo T
Jpn J Clin Oncol; 1990 Jun; 20(2):159-63. PubMed ID: 2164614
[TBL] [Abstract][Full Text] [Related]
32. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
Schenck U; Jütting U; Eiermann W
Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
[TBL] [Abstract][Full Text] [Related]
33. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
Muchiri LW
East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.
Hendricks JB; Wilkinson EJ
Mod Pathol; 1993 Nov; 6(6):765-70. PubMed ID: 7508117
[TBL] [Abstract][Full Text] [Related]
35. Image analysis for quantitation of estrogen receptor in formalin-fixed paraffin-embedded sections of breast carcinoma.
Baddoura FK; Cohen C; Unger ER; DeRose PB; Chenggis M
Mod Pathol; 1991 Jan; 4(1):91-5. PubMed ID: 1708502
[TBL] [Abstract][Full Text] [Related]
36. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
Layfield LJ; Saria EA; Conlon DH; Kerns BJ
J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
[TBL] [Abstract][Full Text] [Related]
37. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
38. Immunodetection in fine-needle aspirates and multiparametric (SAMBA) image analysis. Receptors (monoclonal antiestrogen and antiprogesterone) and growth fraction (monoclonal Ki67) evaluation in breast carcinomas.
Charpin C; Andrac L; Habib MC; Vacheret H; Xerri L; Devictor B; Lavaut MN; Toga M
Cancer; 1989 Mar; 63(5):863-72. PubMed ID: 2644015
[TBL] [Abstract][Full Text] [Related]
39. Comparison of immunocytochemical estrogen receptor assay, estrogen receptor enzyme immunoassay, and radioligand-labeled estrogen receptor assay in human breast cancer and uterine tissue.
Heubner A; Beck T; Grill HJ; Pollow K
Cancer Res; 1986 Aug; 46(8 Suppl):4291s-4295s. PubMed ID: 3524810
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.
von Kleist S; Berling J; Koltzenburg J; Gropp H
J Cancer Res Clin Oncol; 1988; 114(6):623-7. PubMed ID: 2462564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
